Key result
Stellate ganglion block normalises QTc and prevents recurrent Torsades de Pointes in Takotsubo cardiomyopathy.
Why the study?
Patients with Takotsubo cardiomyopathy frequently experience QT prolongation that places them at risk of Torsades de Pointes, while evidence for beta-blockers in arrhythmia prevention is limited and the use of percutaneous stellate ganglion block for TCM-related TdP has rarely been reported.
Does Percutaneous Stellate Ganglion Block prevent recurrent Torsades de Pointes and normalize QTc in a patient with Takotsubo cardiomyopathy and prolonged QTc refractory to beta-blockade?
Case Report (n=1)
No
Does Percutaneous Stellate Ganglion Block prevent recurrent Torsades de Pointes and normalize QTc in a patient with Takotsubo cardiomyopathy and prolonged QTc refractory to beta-blockade?
Answers are grounded in this paper and cite their sources.
Percutaneous stellate ganglion block successfully normalized the QTc interval and terminated recurrent Torsades de Pointes refractory to beta-blockade in an 80-year-old woman with Takotsubo cardiomyopathy.
Structured abstract Background Takotsubo cardiomyopathy (TCM) is characterised by transient apical ballooning of the left ventricle (LV) and accounts for 1-3% of cases of suspected acute coronary syndrome. QT prolongation occurs in most patients with TCM and peaks on approximately day three but may persist for weeks. During this period, patients are at risk of Torsades de Pointes (TdP), which is reported in 2-4% of cases of TCM. Proposed mechanisms for QT prolongation include catecholamine excess, ion channel dysfunction, and repolarisation dispersion from myocardial oedema. Prolonged action potential duration and delayed phase-3 repolarisation predispose to early after-depolarisations (EADs) and subsequent TdP. Case Summary An 80-year-old woman undergoing treatment of acute myeloid leukaemia suffered a TdP-related cardiac arrest. An electrocardiogram demonstrated diffuse T-wave inversion and a corrected QT of 530ms. Echocardiography showed severe hypokinesis of the apical third of the LV - consistent with TCM. Coronary disease was excluded. Her QTc peaked at 635ms and she had recurrent TdP arrests despite beta-blockade. She finally underwent a Percutaneous Stellate Ganglion Block (PSGB) and over the following weeks, her heart rate and QTc normalised without further recurrence of TdP. Discussion Beta-blockers are commonly used in TCM, although evidence for arrhythmia prevention is limited and haemodynamic compromise may limit use. PSGB targets the left cervico-thoracic sympathetic chain, temporarily reducing catecholaminergic outflow. The resulting sympatholysis slows heart rate, shortens the QTc interval, and suppresses EADs —reducing TdP risk. PSGB has shown effectiveness in refractory ventricular tachycardia from different aetiologies; however, its use specifically in TCM-related TdP has rarely been reported.
No takes yet. Share an insight, caveat, or question.
Turner et al. (2026) conducted a case report in Takotsubo cardiomyopathy with Torsades de Pointes (n=1). Percutaneous stellate ganglion block (PSGB) was evaluated on Normalisation of heart rate and QTc without recurrence of Torsades de Pointes. Percutaneous stellate ganglion block normalised heart rate and QTc (from a peak of 635 ms) and prevented recurrent Torsades de Pointes in an 80-year-old woman with Takotsubo cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: